Article Summary
李朝喜 刘杨 刘俊峰 徐大奎 杨瑞敏.彩色多普勒超声对乳腺癌新辅助化疗疗效的评价研究[J].现代生物医学进展英文版,2015,15(17):3325-3328.
彩色多普勒超声对乳腺癌新辅助化疗疗效的评价研究
Study of Color Doppler Flow Imaging in Evaluating Effect ofNeoadjuvant Chemotherapy to Breast Carcinoma
  
DOI:
中文关键词: 乳腺癌  彩色多普勒超声  新辅助  化疗
英文关键词: Breast carcinoma  Color Doppler flow imaging  Neoadjuvant  Chemotherapy
基金项目:
Author NameAffiliation
李朝喜 刘杨 刘俊峰 徐大奎 杨瑞敏 河北北方学院附属第一医院超声医学科河北北方学院附属第一医院门诊部 
Hits: 661
Download times: 818
中文摘要:
      目的:探讨彩色多普勒超声(CDFI)对乳腺癌新辅助化疗(NCT)疗效评价的临床应用价值。方法:选取2013 年1 月~2013 年12 月在我院接受新辅助化疗后行手术治疗的女性乳腺癌患者55 例,以病理学评价为金标准,化疗后根据化疗效果分为有效 组和无效组,利用CDFI观察患者NCT 前后病灶超声指标、病灶内血流分级及阻力指数(RI)值变化。结果:55 例患者中,临床触诊 疗效评价符合率为36.4%,敏感度为60.7%;CDFI评价符合率为70.9%,敏感度为85.7%。CDFI检查显示,乳腺癌NCT 后原发肿 瘤病灶大小显著缩小,边界多清晰可见,内部回声及后方回声倾向正常。有效组NCT 前后病灶内的血流类型和RI值变化有统计 学意义(P<0.05),无效组NCT 前后病灶内的血流类型和RI 值无明显变化(P>0.05)。结论:CDFI技术可对乳腺癌NCT 前后病 灶大小及病灶内部血流动力学变化提供客观参数,是评价乳腺癌NCT疗效的有效方法。
英文摘要:
      Objective:To explore the value of the color Doppler flow imaging in ecaluating effect of neoadjuvant chemotherapy to breast carcinoma.Methods:Selected 55 women patients with breast cancer who received neoadjuvant chemotherapy,and underwent operation treatment in our hospital from January 2013 to December 2013, according to the pathological evaluation for the gold standard, the patients were divided into effective group and ineffective group according to the chemotherapy effect after chemotherapy. The index of ultrasound, the degree of blood flow and hemodynamics index of the tumor were observed by using color Doppler flow imaging.Results:The coincidence rate of clinical palpation for evaluating efficacy was 36.4%, the sensitivity was 60.7% in 55 cases; CDFI evaluation of the coincidence rate was 70.9%, the sensitivity was 85.7%. CDFI examination revealed, the border became more clearly, decrease of tumor lesion size, internal echo and rear echo tend to be normal after neoadjuvant chemotherapy. In effective group, the differences of the blood mode and RI value of the breast tumors between before and after chemotherapy were significant (P<0.05). In ineffective group, there was no significant difference in the blood mode and RI value of the breast tumors between before and after chemotherapy (P>0.05).Conclusion:The color Doppler flow imaging technology can provide objective parameters on lesion size and lesion internal hemodynamic changes before and after accepted neoadjuvant therapy in breast carcinoma, which is an effective method for evaluating the effect of neoadjuvant chemotherapy on breast carcinoma.
View Full Text   View/Add Comment  Download reader
Close